Citadel Advisors
DMTK

Citadel Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History

Citadel Advisors’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,500
Closed -$3.86K – 15754
2024
Q1 		$3.86K Buy
5,500
+700
+15% +$791 ﹤0.01% 13864
2023
Q4 		$8.4K Sell
4,800
-4,000
-45% -$5.84K ﹤0.01% 13224
2023
Q3 		$12.7K Buy
8,800
+1,100
+14% +$2.75K ﹤0.01% 12956
2023
Q2 		$20K Sell
7,700
-24,200
-76% -$72.4K ﹤0.01% 12726
2023
Q1 		$117K Buy
31,900
+9,100
+40% +$38.3K ﹤0.01% 11036
2022
Q4 		$40.4K Buy
22,800
+300
+1% +$798 ﹤0.01% 12412
2022
Q3 		$89K Sell
22,500
-3,400
-13% -$20.9K ﹤0.01% 11186
2022
Q2 		$143K Sell
25,900
-25,900
-50% -$212K ﹤0.01% 11034
2022
Q1 		$760K Sell
51,800
-32,500
-39% -$435K ﹤0.01% 8362
2021
Q4 		$1.33M Buy
84,300
+15,200
+22% +$365K ﹤0.01% 7179
2021
Q3 		$2.22M Sell
69,100
-43,200
-38% -$1.52M ﹤0.01% 6092
2021
Q2 		$4.67M Buy
112,300
+21,600
+24% +$887K ﹤0.01% 4596
2021
Q1 		$4.61M Buy
90,700
+71,600
+375% +$3.74M ﹤0.01% 4427
2020
Q4 		$620K Buy
+19,100
New +$271K ﹤0.01% 7748

Other funds holding DMTK

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

Citadel Advisors's DMTK Position: Q2 2024 in Review

Citadel Advisors sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 207,375 shares — an estimated $146K sold.

Citadel Advisors first reported a position in DMTK in Q4 2020 and held it in 13 quarters. The position peaked at $4.21M in Q2 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Citadel Advisors reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 207,375 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $146K.
  • Citadel Advisors first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 13 quarters.
  • Citadel Advisors's DermTech, Inc. Common Stock position peaked at $4.21M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.